Gout in Chronic Kidney Disease (CKD) Defining the Stage of CKD . At least 40% of patients with gout have at least mild CKD (stage 2, defined as glomerular filtration rate [GFR] or creatinine ...

“Chronic kidney disease and gout are more connected than many people realize. In fact, 1 in 4 people living with moderate-to-severe CKD also has gout,” he shared.

Coadministration of methotrexate, an immunomodulator, with Krystexxa has been shown to help reduce the development of antipegloticase antibodies, thereby improving response to treatment in ...

Gout has often been seen as a consequence of lifestyle choices, but new research is rewriting this narrative. An international team studied DNA from 2.6 million individuals, including 120,295 ...

Atom is enrolling patients in the US for a Phase 2b/3 clinical trial of ABP-671, a novel orally administered URAT1 inhibitor, for the treatment of chronic gout (See clinicaltrials.gov NCT05818085).

PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from severe tophaceous gout, according to a case study presented at the ASN Kidney Week.

WATERTOWN, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies ...

Once palpable tophi and symptoms of acute and chronic gout have dissipated, pharmacologic and nonpharmacologic ULT should be maintained indefinitely. 5 PCPs should inform each patient that ULT has ...

Gout is a risk factor for the development of chronic kidney disease (CKD) stage 3 or higher, UK investigators concluded. In a retrospective cohort study that matched 41,446 new gout cases to the ...